Renal Cell Carcinoma Treatment Approved


The FDA has approved Exelixis' cabozantinib (Cabometryx) as a treatment for advanced renal cell carcinoma patients who have received antiangiogenic therapy.

The FDA has approved Exelixis’ cabozantinib (Cabometryx) as a treatment for advanced renal cell carcinoma patients who have received antiangiogenic therapy.

“With [this] announcement, patients with previously treated advanced kidney cancer now have a new option, the first and only approved product demonstrated to help patients live longer, while also delaying the progression of their cancer,” said Michael Morrissey, president and CEO of Exelixis, in a press release. “We are proud to bring new hope to this community, who are looking for more therapies that can help extend lives. Exelixis is committed to making Cabometyx available to patients in need within the next couple weeks.”

In a phase 3 trial, Cabometyx is the first drug to demonstrate clinically meaningful improvements in 3 key efficacy areas: overall survival, progression-free survival, and objective response rate.

Compared with everolimus, Cabometyx was associated with a 42% reduction in the rate of disease progression or death.

Median progression-free survival for the intervention treatment was 7.4 months compared with 3.8 months for patients taking everolimus.

“The efficacy profile demonstrated by Cabometyx in the METEOR trial, now complemented by the overall survival benefit, is highly compelling,” said Toni Choueiri, clinical director at the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute, in a press release.

The most common adverse reactions observed in patients using Cabometryx included diarrhea, fatigue, nausea, and decreased appetite.

Renal cell carcinoma is the most common form of kidney cancer in adults.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.